GlassScriptPhysician profile
Ian Lancaster
NPI 1700413945
$4,678.87
in general payments reported to CMS, 2019-2025
22 companies · $2,621 in 2025
The $2,621 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.65 · 2021: $26.36 · 2022: $181 · 2023: $299 · 2024: $1,529 · 2025: $2,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,073 · Travel and Lodging: $1,106 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,073.15 |
| Travel and Lodging | $1,105.66 |
| Education | $270.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,180.01 | 2024-2025 | Mitraclip, Ensite, Cardiomems |
| Shockwave Medical, INC | $327.35 | 2025 | |
| Angiodynamics, INC. | $295.68 | 2024 | Auryon Laser System 100-120 Vac |
| Inari Medical, INC. | $286.81 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $276.29 | 2024-2025 | Impella |
| Boston Scientific Corporation | $228.17 | 2023-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Medtronic, INC. | $150.64 | 2024 | Hawkone, Micra |
| Stryker Corporation | $147.35 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Livanova USA, INC. | $108.71 | 2023 | Lifesparc |
| Pfizer INC. | $100.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $92.46 | 2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $79.76 | 2024-2025 | |
| Abbvie INC. | $79.28 | 2020-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.74 | 2022-2025 | Jardiance |
| Amgen INC. | $60.14 | 2021-2023 | Otezla, Enbrel |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $56.73 | 2024 | Crosser Iq |
| Actelion Pharmaceuticals US, INC. | $43.30 | 2024-2025 | Opsumit |
| Ucb, INC. | $26.74 | 2023 | Cimzia |
| Teleflex LLC | $22.11 | 2025 | Vascband |
| Fresenius Kabi USA, LLC | $18.57 | 2023 | |
| Fidia Pharma USA INC. | $17.11 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $12.92 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Lancaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.